Period Ending | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 |
Total Revenue
|
8,727,362
|
8,541,261
|
7,672,329
| Cost of Revenue | 2,479,762 | 2,228,069 | 1,762,972 | |
Gross Profit
|
6,247,600
|
6,313,192
|
5,909,357
| |
|
Operating Expenses |
|
Research Development | 803,070 | 725,600 | 619,727 |
|
Selling General and Administrative | 3,686,891 | 2,880,422 | 3,081,408 |
|
Non Recurring | 38,187 | 49,119 | 1,390,938 |
|
Others | 262,686 | 582,369 | 204,104 |
|
|
|
Total Operating Expenses | 4,790,834 | 4,237,510 | 5,296,177 | | |
Operating Income or Loss
|
1,456,766
|
2,075,682
|
613,180
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,422,385 | 115,919 | 154,271 |
|
Earnings Before Interest And Taxes | 2,879,151 | 2,191,601 | 767,451 |
|
Interest Expense |
-
| 8,037 | 16,600 |
|
Income Before Tax | 2,879,151 | 2,183,564 | 750,851 |
|
Income Tax Expense | 490,054 | 404,090 | 402,600 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,389,097 | 1,779,474 | 348,251 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
2,389,097
|
1,779,474
|
348,251
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
$2,389,097
|
$1,779,474
|
$348,251
|
|